nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—NISCH—hypertension	0.16	0.51	CbGaD
Phentolamine—Naphazoline—Propranolol—hypertension	0.0969	0.584	CrCrCtD
Phentolamine—ADRA2B—hypertension	0.0747	0.238	CbGaD
Phentolamine—Antazoline—Bepridil—hypertension	0.0691	0.416	CrCrCtD
Phentolamine—NISCH—Guanabenz—hypertension	0.0481	0.133	CbGbCtD
Phentolamine—ADRA1A—hypertension	0.0463	0.147	CbGaD
Phentolamine—NISCH—Guanfacine—hypertension	0.0447	0.124	CbGbCtD
Phentolamine—ADRA2A—hypertension	0.0327	0.104	CbGaD
Phentolamine—NISCH—Clonidine—hypertension	0.0218	0.0606	CbGbCtD
Phentolamine—ADRA2C—Guanabenz—hypertension	0.0111	0.0307	CbGbCtD
Phentolamine—ADRA1D—Terazosin—hypertension	0.0106	0.0295	CbGbCtD
Phentolamine—ADRA2B—Guanabenz—hypertension	0.0105	0.0291	CbGbCtD
Phentolamine—ADRA2B—Guanfacine—hypertension	0.00975	0.0271	CbGbCtD
Phentolamine—ADRA1D—Fenoldopam—hypertension	0.00962	0.0267	CbGbCtD
Phentolamine—ADRA1D—Doxazosin—hypertension	0.00888	0.0246	CbGbCtD
Phentolamine—ADRA2C—Fenoldopam—hypertension	0.00874	0.0242	CbGbCtD
Phentolamine—ADRA2B—Fenoldopam—hypertension	0.00829	0.023	CbGbCtD
Phentolamine—ADRA2A—Methyldopa—hypertension	0.00797	0.0221	CbGbCtD
Phentolamine—ADRA1B—Terazosin—hypertension	0.00774	0.0215	CbGbCtD
Phentolamine—ADRA1D—Prazosin—hypertension	0.00729	0.0202	CbGbCtD
Phentolamine—ADRA2A—Guanabenz—hypertension	0.00729	0.0202	CbGbCtD
Phentolamine—ADRA1B—Fenoldopam—hypertension	0.007	0.0194	CbGbCtD
Phentolamine—ADRA2A—Guanfacine—hypertension	0.00678	0.0188	CbGbCtD
Phentolamine—ADRA1B—Doxazosin—hypertension	0.00646	0.0179	CbGbCtD
Phentolamine—ADRA1D—Nicardipine—hypertension	0.00629	0.0175	CbGbCtD
Phentolamine—ADRA1D—Carvedilol—hypertension	0.00629	0.0175	CbGbCtD
Phentolamine—ADRA2B—Prazosin—hypertension	0.00628	0.0174	CbGbCtD
Phentolamine—ADRA1A—Terazosin—hypertension	0.00611	0.017	CbGbCtD
Phentolamine—ADRA2A—Fenoldopam—hypertension	0.00576	0.016	CbGbCtD
Phentolamine—ADRA1B—vas deferens—hypertension	0.00572	0.323	CbGeAlD
Phentolamine—ADRA2C—Carvedilol—hypertension	0.00571	0.0159	CbGbCtD
Phentolamine—ADRA1A—Fenoldopam—hypertension	0.00553	0.0153	CbGbCtD
Phentolamine—ADRA1D—Clonidine—hypertension	0.00553	0.0153	CbGbCtD
Phentolamine—ADRA2B—Carvedilol—hypertension	0.00542	0.015	CbGbCtD
Phentolamine—ADRA2A—Doxazosin—hypertension	0.00532	0.0148	CbGbCtD
Phentolamine—ADRA1B—Prazosin—hypertension	0.00531	0.0147	CbGbCtD
Phentolamine—ADRA1A—Doxazosin—hypertension	0.0051	0.0142	CbGbCtD
Phentolamine—ADRA2C—Clonidine—hypertension	0.00502	0.0139	CbGbCtD
Phentolamine—ADRA2B—Clonidine—hypertension	0.00476	0.0132	CbGbCtD
Phentolamine—ADRA1B—Carvedilol—hypertension	0.00458	0.0127	CbGbCtD
Phentolamine—ADRA1B—Nicardipine—hypertension	0.00458	0.0127	CbGbCtD
Phentolamine—ADRA2A—Prazosin—hypertension	0.00437	0.0121	CbGbCtD
Phentolamine—ADRA1A—Prazosin—hypertension	0.00419	0.0116	CbGbCtD
Phentolamine—ADRA1B—Clonidine—hypertension	0.00402	0.0112	CbGbCtD
Phentolamine—ADRA2A—Carvedilol—hypertension	0.00377	0.0105	CbGbCtD
Phentolamine—ADRA1A—Nicardipine—hypertension	0.00361	0.01	CbGbCtD
Phentolamine—ADRA1A—Carvedilol—hypertension	0.00361	0.01	CbGbCtD
Phentolamine—ADRA2A—Clonidine—hypertension	0.00331	0.00919	CbGbCtD
Phentolamine—ADRA1A—Clonidine—hypertension	0.00317	0.00881	CbGbCtD
Phentolamine—Naphazoline—NISCH—hypertension	0.00099	0.51	CrCbGaD
Phentolamine—NISCH—myocardium—hypertension	0.000612	0.0346	CbGeAlD
Phentolamine—Naphazoline—ADRA2B—hypertension	0.000462	0.238	CrCbGaD
Phentolamine—NISCH—nephron tubule—hypertension	0.000449	0.0254	CbGeAlD
Phentolamine—NISCH—adrenal cortex—hypertension	0.000442	0.025	CbGeAlD
Phentolamine—NISCH—heart—hypertension	0.000427	0.0241	CbGeAlD
Phentolamine—NISCH—smooth muscle tissue—hypertension	0.000424	0.024	CbGeAlD
Phentolamine—NISCH—decidua—hypertension	0.000415	0.0235	CbGeAlD
Phentolamine—NISCH—cortex of kidney—hypertension	0.000384	0.0217	CbGeAlD
Phentolamine—SIGMAR1—cardiac ventricle—hypertension	0.000378	0.0214	CbGeAlD
Phentolamine—SIGMAR1—myocardium—hypertension	0.000356	0.0201	CbGeAlD
Phentolamine—NISCH—medulla oblongata—hypertension	0.000344	0.0195	CbGeAlD
Phentolamine—ADRA1B—kidney—hypertension	0.000336	0.019	CbGeAlD
Phentolamine—NISCH—adrenal gland—hypertension	0.000319	0.018	CbGeAlD
Phentolamine—ADRA2C—cardiac ventricle—hypertension	0.000297	0.0168	CbGeAlD
Phentolamine—Naphazoline—ADRA1A—hypertension	0.000286	0.147	CrCbGaD
Phentolamine—ADRA2C—myocardium—hypertension	0.000279	0.0158	CbGeAlD
Phentolamine—SIGMAR1—nephron tubule—hypertension	0.000261	0.0148	CbGeAlD
Phentolamine—SIGMAR1—adrenal cortex—hypertension	0.000257	0.0145	CbGeAlD
Phentolamine—SIGMAR1—heart—hypertension	0.000248	0.014	CbGeAlD
Phentolamine—SIGMAR1—smooth muscle tissue—hypertension	0.000246	0.0139	CbGeAlD
Phentolamine—SIGMAR1—decidua—hypertension	0.000242	0.0137	CbGeAlD
Phentolamine—ADRA1A—brainstem—hypertension	0.000237	0.0134	CbGeAlD
Phentolamine—ADRA1D—endocrine gland—hypertension	0.000231	0.013	CbGeAlD
Phentolamine—SIGMAR1—cortex of kidney—hypertension	0.000223	0.0126	CbGeAlD
Phentolamine—ADRA1B—central nervous system—hypertension	0.000212	0.012	CbGeAlD
Phentolamine—SIGMAR1—cardiac atrium—hypertension	0.000212	0.012	CbGeAlD
Phentolamine—ADRA1D—central nervous system—hypertension	0.000208	0.0118	CbGeAlD
Phentolamine—ADRA2C—nephron tubule—hypertension	0.000205	0.0116	CbGeAlD
Phentolamine—ADRA1A—heart—hypertension	0.000205	0.0116	CbGeAlD
Phentolamine—Naphazoline—ADRA2A—hypertension	0.000203	0.104	CrCbGaD
Phentolamine—ADRA2C—adrenal cortex—hypertension	0.000202	0.0114	CbGeAlD
Phentolamine—SIGMAR1—medulla oblongata—hypertension	0.0002	0.0113	CbGeAlD
Phentolamine—ADRA2C—heart—hypertension	0.000195	0.011	CbGeAlD
Phentolamine—ADRA1A—cardiovascular system—hypertension	0.000193	0.0109	CbGeAlD
Phentolamine—ADRA2C—decidua—hypertension	0.00019	0.0107	CbGeAlD
Phentolamine—SIGMAR1—adrenal gland—hypertension	0.000185	0.0105	CbGeAlD
Phentolamine—ADRA2C—kidney—hypertension	0.00018	0.0102	CbGeAlD
Phentolamine—ADRA2C—cortex of kidney—hypertension	0.000175	0.00992	CbGeAlD
Phentolamine—ADRA2C—cardiac atrium—hypertension	0.000167	0.00943	CbGeAlD
Phentolamine—ADRA2C—medulla oblongata—hypertension	0.000157	0.00889	CbGeAlD
Phentolamine—ADRA2A—heart—hypertension	0.000156	0.0088	CbGeAlD
Phentolamine—ADRA1A—adrenal gland—hypertension	0.000153	0.00864	CbGeAlD
Phentolamine—ADRA2A—decidua—hypertension	0.000151	0.00856	CbGeAlD
Phentolamine—ADRA2C—adrenal gland—hypertension	0.000146	0.00823	CbGeAlD
Phentolamine—ADRA2A—cortex of kidney—hypertension	0.00014	0.00791	CbGeAlD
Phentolamine—ADRA2A—cardiac atrium—hypertension	0.000133	0.00753	CbGeAlD
Phentolamine—ADRA1A—endocrine gland—hypertension	0.000132	0.00749	CbGeAlD
Phentolamine—ADRA2A—medulla oblongata—hypertension	0.000125	0.0071	CbGeAlD
Phentolamine—ADRA1A—central nervous system—hypertension	0.000119	0.00675	CbGeAlD
Phentolamine—ADRA2A—adrenal gland—hypertension	0.000116	0.00657	CbGeAlD
Phentolamine—ADRA2C—central nervous system—hypertension	0.000114	0.00643	CbGeAlD
Phentolamine—ADRA2A—endocrine gland—hypertension	0.000101	0.0057	CbGeAlD
Phentolamine—ADRA2A—central nervous system—hypertension	9.08e-05	0.00513	CbGeAlD
Phentolamine—Asthenia—Carvedilol—hypertension	4.16e-05	0.000504	CcSEcCtD
Phentolamine—Hypotension—Irbesartan—hypertension	4.16e-05	0.000504	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Trandolapril—hypertension	4.16e-05	0.000504	CcSEcCtD
Phentolamine—Pruritus—Indapamide—hypertension	4.14e-05	0.000502	CcSEcCtD
Phentolamine—Pruritus—Diltiazem—hypertension	4.14e-05	0.000502	CcSEcCtD
Phentolamine—Diarrhoea—Propranolol—hypertension	4.14e-05	0.000501	CcSEcCtD
Phentolamine—Mediastinal disorder—Lisinopril—hypertension	4.13e-05	0.000501	CcSEcCtD
Phentolamine—Paraesthesia—Captopril—hypertension	4.13e-05	0.0005	CcSEcCtD
Phentolamine—Headache—Guanabenz—hypertension	4.13e-05	0.0005	CcSEcCtD
Phentolamine—Headache—Metoprolol—hypertension	4.13e-05	0.0005	CcSEcCtD
Phentolamine—Hypotension—Hydrochlorothiazide—hypertension	4.13e-05	0.0005	CcSEcCtD
Phentolamine—Asthenia—Doxazosin—hypertension	4.11e-05	0.000498	CcSEcCtD
Phentolamine—Nervous system disorder—Losartan—hypertension	4.11e-05	0.000498	CcSEcCtD
Phentolamine—Pruritus—Carvedilol—hypertension	4.1e-05	0.000497	CcSEcCtD
Phentolamine—Arrhythmia—Lisinopril—hypertension	4.1e-05	0.000496	CcSEcCtD
Phentolamine—Abdominal pain—Valsartan—hypertension	4.09e-05	0.000496	CcSEcCtD
Phentolamine—Tachycardia—Losartan—hypertension	4.09e-05	0.000495	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Telmisartan—hypertension	4.08e-05	0.000495	CcSEcCtD
Phentolamine—Abdominal pain—Olmesartan—hypertension	4.07e-05	0.000494	CcSEcCtD
Phentolamine—Asthenia—Fosinopril—hypertension	4.06e-05	0.000492	CcSEcCtD
Phentolamine—Hypotension—Furosemide—hypertension	4.06e-05	0.000492	CcSEcCtD
Phentolamine—Pruritus—Doxazosin—hypertension	4.06e-05	0.000491	CcSEcCtD
Phentolamine—Pain—Telmisartan—hypertension	4.04e-05	0.00049	CcSEcCtD
Phentolamine—Asthenia—Eplerenone—hypertension	4.04e-05	0.000489	CcSEcCtD
Phentolamine—Gastrointestinal pain—Clonidine—hypertension	4.04e-05	0.000489	CcSEcCtD
Phentolamine—Hypotension—Betaxolol—hypertension	4.02e-05	0.000487	CcSEcCtD
Phentolamine—Paraesthesia—Perindopril—hypertension	4.01e-05	0.000486	CcSEcCtD
Phentolamine—Asthenia—Nifedipine—hypertension	4.01e-05	0.000486	CcSEcCtD
Phentolamine—Pruritus—Fosinopril—hypertension	4.01e-05	0.000485	CcSEcCtD
Phentolamine—Diarrhoea—Indapamide—hypertension	4.01e-05	0.000485	CcSEcCtD
Phentolamine—Diarrhoea—Diltiazem—hypertension	4.01e-05	0.000485	CcSEcCtD
Phentolamine—Dizziness—Propranolol—hypertension	4e-05	0.000485	CcSEcCtD
Phentolamine—Paraesthesia—Irbesartan—hypertension	4e-05	0.000484	CcSEcCtD
Phentolamine—Asthenia—Verapamil—hypertension	3.99e-05	0.000484	CcSEcCtD
Phentolamine—Pruritus—Eplerenone—hypertension	3.98e-05	0.000483	CcSEcCtD
Phentolamine—Diarrhoea—Carvedilol—hypertension	3.97e-05	0.000481	CcSEcCtD
Phentolamine—Paraesthesia—Hydrochlorothiazide—hypertension	3.96e-05	0.00048	CcSEcCtD
Phentolamine—Pruritus—Nifedipine—hypertension	3.95e-05	0.000479	CcSEcCtD
Phentolamine—Gastrointestinal pain—Trandolapril—hypertension	3.94e-05	0.000477	CcSEcCtD
Phentolamine—Pruritus—Verapamil—hypertension	3.94e-05	0.000477	CcSEcCtD
Phentolamine—Diarrhoea—Doxazosin—hypertension	3.92e-05	0.000475	CcSEcCtD
Phentolamine—Gastrointestinal pain—Enalapril—hypertension	3.92e-05	0.000475	CcSEcCtD
Phentolamine—Hypotension—Losartan—hypertension	3.91e-05	0.000474	CcSEcCtD
Phentolamine—Nausea—Metoprolol—hypertension	3.91e-05	0.000474	CcSEcCtD
Phentolamine—Nausea—Guanabenz—hypertension	3.91e-05	0.000474	CcSEcCtD
Phentolamine—Abdominal pain—Clonidine—hypertension	3.9e-05	0.000473	CcSEcCtD
Phentolamine—Paraesthesia—Furosemide—hypertension	3.9e-05	0.000472	CcSEcCtD
Phentolamine—Diarrhoea—Fosinopril—hypertension	3.87e-05	0.000469	CcSEcCtD
Phentolamine—Dizziness—Diltiazem—hypertension	3.87e-05	0.000469	CcSEcCtD
Phentolamine—Dizziness—Indapamide—hypertension	3.87e-05	0.000469	CcSEcCtD
Phentolamine—Gastrointestinal pain—Telmisartan—hypertension	3.87e-05	0.000469	CcSEcCtD
Phentolamine—Paraesthesia—Betaxolol—hypertension	3.86e-05	0.000468	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Perindopril—hypertension	3.86e-05	0.000467	CcSEcCtD
Phentolamine—Diarrhoea—Eplerenone—hypertension	3.85e-05	0.000467	CcSEcCtD
Phentolamine—Vomiting—Propranolol—hypertension	3.85e-05	0.000466	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Irbesartan—hypertension	3.84e-05	0.000466	CcSEcCtD
Phentolamine—Dizziness—Carvedilol—hypertension	3.83e-05	0.000464	CcSEcCtD
Phentolamine—Diarrhoea—Nifedipine—hypertension	3.82e-05	0.000463	CcSEcCtD
Phentolamine—Pain—Perindopril—hypertension	3.82e-05	0.000463	CcSEcCtD
Phentolamine—Abdominal pain—Trandolapril—hypertension	3.81e-05	0.000461	CcSEcCtD
Phentolamine—Diarrhoea—Verapamil—hypertension	3.81e-05	0.000461	CcSEcCtD
Phentolamine—Pain—Irbesartan—hypertension	3.81e-05	0.000461	CcSEcCtD
Phentolamine—Dizziness—Doxazosin—hypertension	3.79e-05	0.000459	CcSEcCtD
Phentolamine—Abdominal pain—Enalapril—hypertension	3.79e-05	0.000459	CcSEcCtD
Phentolamine—Pain—Hydrochlorothiazide—hypertension	3.78e-05	0.000457	CcSEcCtD
Phentolamine—Paraesthesia—Losartan—hypertension	3.76e-05	0.000456	CcSEcCtD
Phentolamine—Gastrointestinal pain—Captopril—hypertension	3.76e-05	0.000456	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Furosemide—hypertension	3.75e-05	0.000454	CcSEcCtD
Phentolamine—Chest pain—Ramipril—hypertension	3.75e-05	0.000454	CcSEcCtD
Phentolamine—Dizziness—Fosinopril—hypertension	3.74e-05	0.000454	CcSEcCtD
Phentolamine—Abdominal pain—Telmisartan—hypertension	3.74e-05	0.000453	CcSEcCtD
Phentolamine—Dizziness—Eplerenone—hypertension	3.72e-05	0.000451	CcSEcCtD
Phentolamine—Vomiting—Diltiazem—hypertension	3.72e-05	0.000451	CcSEcCtD
Phentolamine—Vomiting—Indapamide—hypertension	3.72e-05	0.000451	CcSEcCtD
Phentolamine—Asthenia—Valsartan—hypertension	3.72e-05	0.00045	CcSEcCtD
Phentolamine—Hypertension—Timolol—hypertension	3.71e-05	0.00045	CcSEcCtD
Phentolamine—Pain—Furosemide—hypertension	3.71e-05	0.00045	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Betaxolol—hypertension	3.71e-05	0.00045	CcSEcCtD
Phentolamine—Asthenia—Olmesartan—hypertension	3.7e-05	0.000448	CcSEcCtD
Phentolamine—Dizziness—Nifedipine—hypertension	3.69e-05	0.000448	CcSEcCtD
Phentolamine—Vomiting—Carvedilol—hypertension	3.69e-05	0.000447	CcSEcCtD
Phentolamine—Dizziness—Verapamil—hypertension	3.68e-05	0.000446	CcSEcCtD
Phentolamine—Pain—Betaxolol—hypertension	3.68e-05	0.000445	CcSEcCtD
Phentolamine—Headache—Diltiazem—hypertension	3.67e-05	0.000444	CcSEcCtD
Phentolamine—Headache—Indapamide—hypertension	3.67e-05	0.000444	CcSEcCtD
Phentolamine—Pruritus—Valsartan—hypertension	3.66e-05	0.000444	CcSEcCtD
Phentolamine—Chest pain—Timolol—hypertension	3.66e-05	0.000444	CcSEcCtD
Phentolamine—Gastrointestinal pain—Perindopril—hypertension	3.65e-05	0.000442	CcSEcCtD
Phentolamine—Pruritus—Olmesartan—hypertension	3.65e-05	0.000442	CcSEcCtD
Phentolamine—Vomiting—Doxazosin—hypertension	3.65e-05	0.000442	CcSEcCtD
Phentolamine—Gastrointestinal pain—Irbesartan—hypertension	3.64e-05	0.000441	CcSEcCtD
Phentolamine—Abdominal pain—Captopril—hypertension	3.64e-05	0.000441	CcSEcCtD
Phentolamine—Headache—Carvedilol—hypertension	3.63e-05	0.00044	CcSEcCtD
Phentolamine—Gastrointestinal pain—Hydrochlorothiazide—hypertension	3.61e-05	0.000437	CcSEcCtD
Phentolamine—Vomiting—Fosinopril—hypertension	3.6e-05	0.000436	CcSEcCtD
Phentolamine—Nausea—Propranolol—hypertension	3.59e-05	0.000435	CcSEcCtD
Phentolamine—Headache—Doxazosin—hypertension	3.59e-05	0.000435	CcSEcCtD
Phentolamine—Pain—Losartan—hypertension	3.58e-05	0.000434	CcSEcCtD
Phentolamine—Vomiting—Eplerenone—hypertension	3.58e-05	0.000434	CcSEcCtD
Phentolamine—Vomiting—Nifedipine—hypertension	3.55e-05	0.00043	CcSEcCtD
Phentolamine—Gastrointestinal pain—Furosemide—hypertension	3.55e-05	0.00043	CcSEcCtD
Phentolamine—Headache—Fosinopril—hypertension	3.55e-05	0.00043	CcSEcCtD
Phentolamine—Diarrhoea—Valsartan—hypertension	3.54e-05	0.000429	CcSEcCtD
Phentolamine—Asthenia—Clonidine—hypertension	3.54e-05	0.000429	CcSEcCtD
Phentolamine—Vomiting—Verapamil—hypertension	3.54e-05	0.000429	CcSEcCtD
Phentolamine—Abdominal pain—Perindopril—hypertension	3.53e-05	0.000428	CcSEcCtD
Phentolamine—Diarrhoea—Olmesartan—hypertension	3.53e-05	0.000427	CcSEcCtD
Phentolamine—Headache—Eplerenone—hypertension	3.53e-05	0.000427	CcSEcCtD
Phentolamine—Nervous system disorder—Ramipril—hypertension	3.52e-05	0.000427	CcSEcCtD
Phentolamine—Abdominal pain—Irbesartan—hypertension	3.52e-05	0.000426	CcSEcCtD
Phentolamine—Tachycardia—Ramipril—hypertension	3.51e-05	0.000425	CcSEcCtD
Phentolamine—Headache—Nifedipine—hypertension	3.5e-05	0.000424	CcSEcCtD
Phentolamine—Pruritus—Clonidine—hypertension	3.49e-05	0.000423	CcSEcCtD
Phentolamine—Abdominal pain—Hydrochlorothiazide—hypertension	3.49e-05	0.000423	CcSEcCtD
Phentolamine—Headache—Verapamil—hypertension	3.49e-05	0.000422	CcSEcCtD
Phentolamine—Nausea—Diltiazem—hypertension	3.48e-05	0.000421	CcSEcCtD
Phentolamine—Nausea—Indapamide—hypertension	3.48e-05	0.000421	CcSEcCtD
Phentolamine—Asthenia—Trandolapril—hypertension	3.45e-05	0.000419	CcSEcCtD
Phentolamine—Nervous system disorder—Timolol—hypertension	3.44e-05	0.000417	CcSEcCtD
Phentolamine—Nausea—Carvedilol—hypertension	3.44e-05	0.000417	CcSEcCtD
Phentolamine—Asthenia—Enalapril—hypertension	3.44e-05	0.000417	CcSEcCtD
Phentolamine—Abdominal pain—Furosemide—hypertension	3.43e-05	0.000416	CcSEcCtD
Phentolamine—Gastrointestinal pain—Losartan—hypertension	3.43e-05	0.000415	CcSEcCtD
Phentolamine—Dizziness—Valsartan—hypertension	3.42e-05	0.000415	CcSEcCtD
Phentolamine—Dizziness—Olmesartan—hypertension	3.41e-05	0.000413	CcSEcCtD
Phentolamine—Pruritus—Trandolapril—hypertension	3.41e-05	0.000413	CcSEcCtD
Phentolamine—Nausea—Doxazosin—hypertension	3.41e-05	0.000413	CcSEcCtD
Phentolamine—Chest pain—Lisinopril—hypertension	3.4e-05	0.000412	CcSEcCtD
Phentolamine—Asthenia—Telmisartan—hypertension	3.39e-05	0.000411	CcSEcCtD
Phentolamine—Pruritus—Enalapril—hypertension	3.39e-05	0.000411	CcSEcCtD
Phentolamine—Diarrhoea—Clonidine—hypertension	3.38e-05	0.000409	CcSEcCtD
Phentolamine—Nausea—Fosinopril—hypertension	3.36e-05	0.000408	CcSEcCtD
Phentolamine—Hypotension—Ramipril—hypertension	3.36e-05	0.000407	CcSEcCtD
Phentolamine—Pruritus—Telmisartan—hypertension	3.35e-05	0.000405	CcSEcCtD
Phentolamine—Nausea—Eplerenone—hypertension	3.34e-05	0.000405	CcSEcCtD
Phentolamine—Nausea—Nifedipine—hypertension	3.32e-05	0.000402	CcSEcCtD
Phentolamine—Abdominal pain—Losartan—hypertension	3.31e-05	0.000401	CcSEcCtD
Phentolamine—Nausea—Verapamil—hypertension	3.3e-05	0.0004	CcSEcCtD
Phentolamine—Asthenia—Captopril—hypertension	3.3e-05	0.0004	CcSEcCtD
Phentolamine—Diarrhoea—Trandolapril—hypertension	3.29e-05	0.000399	CcSEcCtD
Phentolamine—Vomiting—Valsartan—hypertension	3.29e-05	0.000399	CcSEcCtD
Phentolamine—Diarrhoea—Enalapril—hypertension	3.28e-05	0.000398	CcSEcCtD
Phentolamine—Hypotension—Timolol—hypertension	3.28e-05	0.000398	CcSEcCtD
Phentolamine—Vomiting—Olmesartan—hypertension	3.28e-05	0.000397	CcSEcCtD
Phentolamine—Dizziness—Clonidine—hypertension	3.26e-05	0.000396	CcSEcCtD
Phentolamine—Pruritus—Captopril—hypertension	3.25e-05	0.000394	CcSEcCtD
Phentolamine—Headache—Valsartan—hypertension	3.24e-05	0.000393	CcSEcCtD
Phentolamine—Diarrhoea—Telmisartan—hypertension	3.24e-05	0.000392	CcSEcCtD
Phentolamine—Headache—Olmesartan—hypertension	3.23e-05	0.000391	CcSEcCtD
Phentolamine—Paraesthesia—Ramipril—hypertension	3.23e-05	0.000391	CcSEcCtD
Phentolamine—Asthenia—Perindopril—hypertension	3.2e-05	0.000388	CcSEcCtD
Phentolamine—Asthenia—Irbesartan—hypertension	3.19e-05	0.000387	CcSEcCtD
Phentolamine—Dizziness—Trandolapril—hypertension	3.18e-05	0.000386	CcSEcCtD
Phentolamine—Tachycardia—Lisinopril—hypertension	3.18e-05	0.000385	CcSEcCtD
Phentolamine—Dizziness—Enalapril—hypertension	3.17e-05	0.000384	CcSEcCtD
Phentolamine—Asthenia—Hydrochlorothiazide—hypertension	3.17e-05	0.000384	CcSEcCtD
Phentolamine—Pruritus—Perindopril—hypertension	3.16e-05	0.000383	CcSEcCtD
Phentolamine—Paraesthesia—Timolol—hypertension	3.15e-05	0.000382	CcSEcCtD
Phentolamine—Pruritus—Irbesartan—hypertension	3.15e-05	0.000382	CcSEcCtD
Phentolamine—Diarrhoea—Captopril—hypertension	3.15e-05	0.000381	CcSEcCtD
Phentolamine—Vomiting—Clonidine—hypertension	3.14e-05	0.00038	CcSEcCtD
Phentolamine—Dizziness—Telmisartan—hypertension	3.13e-05	0.000379	CcSEcCtD
Phentolamine—Pruritus—Hydrochlorothiazide—hypertension	3.12e-05	0.000378	CcSEcCtD
Phentolamine—Asthenia—Furosemide—hypertension	3.11e-05	0.000377	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Ramipril—hypertension	3.1e-05	0.000376	CcSEcCtD
Phentolamine—Headache—Clonidine—hypertension	3.09e-05	0.000375	CcSEcCtD
Phentolamine—Asthenia—Betaxolol—hypertension	3.08e-05	0.000374	CcSEcCtD
Phentolamine—Nausea—Valsartan—hypertension	3.08e-05	0.000373	CcSEcCtD
Phentolamine—Pruritus—Furosemide—hypertension	3.07e-05	0.000372	CcSEcCtD
Phentolamine—Nausea—Olmesartan—hypertension	3.06e-05	0.000371	CcSEcCtD
Phentolamine—Vomiting—Trandolapril—hypertension	3.06e-05	0.000371	CcSEcCtD
Phentolamine—Diarrhoea—Perindopril—hypertension	3.06e-05	0.00037	CcSEcCtD
Phentolamine—Vomiting—Enalapril—hypertension	3.05e-05	0.000369	CcSEcCtD
Phentolamine—Diarrhoea—Irbesartan—hypertension	3.05e-05	0.000369	CcSEcCtD
Phentolamine—Hypotension—Lisinopril—hypertension	3.04e-05	0.000369	CcSEcCtD
Phentolamine—Dizziness—Captopril—hypertension	3.04e-05	0.000369	CcSEcCtD
Phentolamine—Pruritus—Betaxolol—hypertension	3.04e-05	0.000368	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Timolol—hypertension	3.03e-05	0.000367	CcSEcCtD
Phentolamine—Diarrhoea—Hydrochlorothiazide—hypertension	3.02e-05	0.000366	CcSEcCtD
Phentolamine—Headache—Trandolapril—hypertension	3.02e-05	0.000365	CcSEcCtD
Phentolamine—Vomiting—Telmisartan—hypertension	3.01e-05	0.000364	CcSEcCtD
Phentolamine—Asthenia—Losartan—hypertension	3.01e-05	0.000364	CcSEcCtD
Phentolamine—Headache—Enalapril—hypertension	3e-05	0.000364	CcSEcCtD
Phentolamine—Pain—Timolol—hypertension	3e-05	0.000364	CcSEcCtD
Phentolamine—Diarrhoea—Furosemide—hypertension	2.97e-05	0.00036	CcSEcCtD
Phentolamine—Pruritus—Losartan—hypertension	2.96e-05	0.000359	CcSEcCtD
Phentolamine—Headache—Telmisartan—hypertension	2.96e-05	0.000359	CcSEcCtD
Phentolamine—Dizziness—Perindopril—hypertension	2.95e-05	0.000358	CcSEcCtD
Phentolamine—Dizziness—Irbesartan—hypertension	2.94e-05	0.000357	CcSEcCtD
Phentolamine—Diarrhoea—Betaxolol—hypertension	2.94e-05	0.000356	CcSEcCtD
Phentolamine—Gastrointestinal pain—Ramipril—hypertension	2.94e-05	0.000356	CcSEcCtD
Phentolamine—Nausea—Clonidine—hypertension	2.93e-05	0.000355	CcSEcCtD
Phentolamine—Paraesthesia—Lisinopril—hypertension	2.92e-05	0.000354	CcSEcCtD
Phentolamine—Vomiting—Captopril—hypertension	2.92e-05	0.000354	CcSEcCtD
Phentolamine—Dizziness—Hydrochlorothiazide—hypertension	2.92e-05	0.000354	CcSEcCtD
Phentolamine—Headache—Captopril—hypertension	2.88e-05	0.000349	CcSEcCtD
Phentolamine—Gastrointestinal pain—Timolol—hypertension	2.87e-05	0.000348	CcSEcCtD
Phentolamine—Dizziness—Furosemide—hypertension	2.87e-05	0.000348	CcSEcCtD
Phentolamine—Diarrhoea—Losartan—hypertension	2.87e-05	0.000347	CcSEcCtD
Phentolamine—Nausea—Trandolapril—hypertension	2.86e-05	0.000347	CcSEcCtD
Phentolamine—Nausea—Enalapril—hypertension	2.85e-05	0.000345	CcSEcCtD
Phentolamine—Dizziness—Betaxolol—hypertension	2.84e-05	0.000344	CcSEcCtD
Phentolamine—Vomiting—Perindopril—hypertension	2.84e-05	0.000344	CcSEcCtD
Phentolamine—Abdominal pain—Ramipril—hypertension	2.84e-05	0.000344	CcSEcCtD
Phentolamine—Vomiting—Irbesartan—hypertension	2.83e-05	0.000343	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Lisinopril—hypertension	2.81e-05	0.000341	CcSEcCtD
Phentolamine—Nausea—Telmisartan—hypertension	2.81e-05	0.00034	CcSEcCtD
Phentolamine—Vomiting—Hydrochlorothiazide—hypertension	2.81e-05	0.00034	CcSEcCtD
Phentolamine—Headache—Perindopril—hypertension	2.8e-05	0.000339	CcSEcCtD
Phentolamine—Headache—Irbesartan—hypertension	2.79e-05	0.000338	CcSEcCtD
Phentolamine—Pain—Lisinopril—hypertension	2.79e-05	0.000338	CcSEcCtD
Phentolamine—Abdominal pain—Timolol—hypertension	2.78e-05	0.000336	CcSEcCtD
Phentolamine—Dizziness—Losartan—hypertension	2.77e-05	0.000336	CcSEcCtD
Phentolamine—Headache—Hydrochlorothiazide—hypertension	2.77e-05	0.000335	CcSEcCtD
Phentolamine—Vomiting—Furosemide—hypertension	2.76e-05	0.000334	CcSEcCtD
Phentolamine—Vomiting—Betaxolol—hypertension	2.73e-05	0.000331	CcSEcCtD
Phentolamine—Nausea—Captopril—hypertension	2.73e-05	0.000331	CcSEcCtD
Phentolamine—Headache—Furosemide—hypertension	2.72e-05	0.00033	CcSEcCtD
Phentolamine—Headache—Betaxolol—hypertension	2.69e-05	0.000326	CcSEcCtD
Phentolamine—Gastrointestinal pain—Lisinopril—hypertension	2.66e-05	0.000323	CcSEcCtD
Phentolamine—Vomiting—Losartan—hypertension	2.66e-05	0.000323	CcSEcCtD
Phentolamine—Nausea—Perindopril—hypertension	2.65e-05	0.000321	CcSEcCtD
Phentolamine—Nausea—Irbesartan—hypertension	2.64e-05	0.00032	CcSEcCtD
Phentolamine—Headache—Losartan—hypertension	2.62e-05	0.000318	CcSEcCtD
Phentolamine—Nausea—Hydrochlorothiazide—hypertension	2.62e-05	0.000318	CcSEcCtD
Phentolamine—Nausea—Furosemide—hypertension	2.58e-05	0.000312	CcSEcCtD
Phentolamine—Asthenia—Ramipril—hypertension	2.58e-05	0.000312	CcSEcCtD
Phentolamine—Abdominal pain—Lisinopril—hypertension	2.57e-05	0.000312	CcSEcCtD
Phentolamine—Nausea—Betaxolol—hypertension	2.55e-05	0.000309	CcSEcCtD
Phentolamine—Pruritus—Ramipril—hypertension	2.54e-05	0.000308	CcSEcCtD
Phentolamine—Asthenia—Timolol—hypertension	2.52e-05	0.000305	CcSEcCtD
Phentolamine—Nausea—Losartan—hypertension	2.49e-05	0.000301	CcSEcCtD
Phentolamine—Pruritus—Timolol—hypertension	2.48e-05	0.000301	CcSEcCtD
Phentolamine—Diarrhoea—Ramipril—hypertension	2.46e-05	0.000298	CcSEcCtD
Phentolamine—Diarrhoea—Timolol—hypertension	2.4e-05	0.000291	CcSEcCtD
Phentolamine—Dizziness—Ramipril—hypertension	2.38e-05	0.000288	CcSEcCtD
Phentolamine—Asthenia—Lisinopril—hypertension	2.34e-05	0.000283	CcSEcCtD
Phentolamine—Dizziness—Timolol—hypertension	2.32e-05	0.000281	CcSEcCtD
Phentolamine—Pruritus—Lisinopril—hypertension	2.3e-05	0.000279	CcSEcCtD
Phentolamine—Vomiting—Ramipril—hypertension	2.28e-05	0.000277	CcSEcCtD
Phentolamine—Headache—Ramipril—hypertension	2.25e-05	0.000273	CcSEcCtD
Phentolamine—Vomiting—Timolol—hypertension	2.23e-05	0.00027	CcSEcCtD
Phentolamine—Diarrhoea—Lisinopril—hypertension	2.23e-05	0.00027	CcSEcCtD
Phentolamine—Headache—Timolol—hypertension	2.2e-05	0.000267	CcSEcCtD
Phentolamine—Dizziness—Lisinopril—hypertension	2.15e-05	0.000261	CcSEcCtD
Phentolamine—Nausea—Ramipril—hypertension	2.13e-05	0.000258	CcSEcCtD
Phentolamine—Nausea—Timolol—hypertension	2.09e-05	0.000253	CcSEcCtD
Phentolamine—Vomiting—Lisinopril—hypertension	2.07e-05	0.000251	CcSEcCtD
Phentolamine—Headache—Lisinopril—hypertension	2.04e-05	0.000247	CcSEcCtD
Phentolamine—Nausea—Lisinopril—hypertension	1.93e-05	0.000234	CcSEcCtD
Phentolamine—ADRA1B—Signaling Pathways—KDR—hypertension	1.31e-06	2.27e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CAV1—hypertension	1.31e-06	2.26e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—H2AFX—hypertension	1.31e-06	2.26e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PRKCD—hypertension	1.31e-06	2.26e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCR5—hypertension	1.31e-06	2.26e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RPS6KB1—hypertension	1.3e-06	2.26e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PDGFRB—hypertension	1.3e-06	2.26e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—APOA1—hypertension	1.3e-06	2.26e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ADCY5—hypertension	1.29e-06	2.23e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—FN1—hypertension	1.28e-06	2.22e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—F2—hypertension	1.28e-06	2.22e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PRKCB—hypertension	1.28e-06	2.22e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PRKCG—hypertension	1.28e-06	2.21e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HTR2A—hypertension	1.28e-06	2.21e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—C3—hypertension	1.28e-06	2.21e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ALB—hypertension	1.27e-06	2.2e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ITGB3—hypertension	1.27e-06	2.2e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PRKCA—hypertension	1.27e-06	2.2e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—SERPINE1—hypertension	1.26e-06	2.19e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—YWHAZ—hypertension	1.26e-06	2.18e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—F2—hypertension	1.26e-06	2.18e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—FN1—hypertension	1.26e-06	2.18e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PRKCB—hypertension	1.26e-06	2.18e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NOTCH1—hypertension	1.25e-06	2.17e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—POMC—hypertension	1.25e-06	2.16e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SPP1—hypertension	1.25e-06	2.16e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NGF—hypertension	1.25e-06	2.16e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—INS—hypertension	1.24e-06	2.15e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PDGFB—hypertension	1.24e-06	2.15e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CXCL8—hypertension	1.24e-06	2.15e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—FGFR1—hypertension	1.23e-06	2.14e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NOTCH1—hypertension	1.23e-06	2.13e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—FGF2—hypertension	1.22e-06	2.12e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCL2—hypertension	1.22e-06	2.11e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—RHOA—hypertension	1.22e-06	2.11e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PIK3R1—hypertension	1.22e-06	2.11e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—NOS3—hypertension	1.22e-06	2.11e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HIF1A—hypertension	1.22e-06	2.1e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCR5—hypertension	1.21e-06	2.1e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PRKCD—hypertension	1.21e-06	2.1e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—AGT—hypertension	1.21e-06	2.1e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NOS3—hypertension	1.21e-06	2.09e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PIK3R1—hypertension	1.21e-06	2.09e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IGF1—hypertension	1.2e-06	2.08e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—AKT2—hypertension	1.2e-06	2.08e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—EGFR—hypertension	1.2e-06	2.07e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CALM1—hypertension	1.19e-06	2.06e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—LEP—hypertension	1.19e-06	2.05e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—APOE—hypertension	1.19e-06	2.05e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HTR2A—hypertension	1.19e-06	2.05e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—C3—hypertension	1.18e-06	2.05e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CAV1—hypertension	1.18e-06	2.03e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—APOA1—hypertension	1.17e-06	2.03e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—POMC—hypertension	1.17e-06	2.02e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—KDR—hypertension	1.16e-06	2.01e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—INS—hypertension	1.16e-06	2.01e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PDGFB—hypertension	1.15e-06	2e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PPARG—hypertension	1.15e-06	1.99e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—POMC—hypertension	1.15e-06	1.99e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—FGFR1—hypertension	1.15e-06	1.98e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—INS—hypertension	1.14e-06	1.98e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCL2—hypertension	1.14e-06	1.97e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SERPINE1—hypertension	1.14e-06	1.97e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—RELA—hypertension	1.14e-06	1.96e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—POMC—hypertension	1.13e-06	1.96e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HIF1A—hypertension	1.13e-06	1.95e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—INS—hypertension	1.13e-06	1.95e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—AGT—hypertension	1.13e-06	1.95e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCL2—hypertension	1.12e-06	1.94e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IGF1—hypertension	1.12e-06	1.94e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—AKT2—hypertension	1.12e-06	1.94e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—AKT1—hypertension	1.12e-06	1.94e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—FN1—hypertension	1.12e-06	1.94e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PRKCB—hypertension	1.12e-06	1.94e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—F2—hypertension	1.12e-06	1.94e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—EGFR—hypertension	1.12e-06	1.93e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MTOR—hypertension	1.11e-06	1.93e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PTGS2—hypertension	1.11e-06	1.93e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CALM1—hypertension	1.11e-06	1.92e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IGF1—hypertension	1.1e-06	1.91e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—FGF2—hypertension	1.1e-06	1.91e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—AKT2—hypertension	1.1e-06	1.91e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—APOE—hypertension	1.1e-06	1.91e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—LEP—hypertension	1.1e-06	1.91e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—RHOA—hypertension	1.1e-06	1.9e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—EGFR—hypertension	1.1e-06	1.9e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NOTCH1—hypertension	1.1e-06	1.9e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CAV1—hypertension	1.09e-06	1.89e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—APOA1—hypertension	1.09e-06	1.89e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PIK3R1—hypertension	1.09e-06	1.88e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NOS3—hypertension	1.09e-06	1.88e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—KDR—hypertension	1.08e-06	1.87e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCL8—hypertension	1.07e-06	1.85e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SERPINE1—hypertension	1.07e-06	1.84e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SERPINE1—hypertension	1.05e-06	1.81e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PRKCB—hypertension	1.04e-06	1.8e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—FN1—hypertension	1.04e-06	1.8e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—F2—hypertension	1.04e-06	1.8e-05	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—AKT1—hypertension	1.03e-06	1.79e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ALB—hypertension	1.03e-06	1.79e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—FGF2—hypertension	1.03e-06	1.78e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—RHOA—hypertension	1.03e-06	1.78e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—RELA—hypertension	1.03e-06	1.77e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—POMC—hypertension	1.02e-06	1.76e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NOTCH1—hypertension	1.02e-06	1.76e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL6—hypertension	1.02e-06	1.76e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NOS3—hypertension	1.02e-06	1.76e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PIK3R1—hypertension	1.02e-06	1.76e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—FGF2—hypertension	1.02e-06	1.76e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—INS—hypertension	1.01e-06	1.75e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—RHOA—hypertension	1.01e-06	1.75e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MTOR—hypertension	1.01e-06	1.74e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PIK3R1—hypertension	1e-06	1.73e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NOS3—hypertension	1e-06	1.73e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCL2—hypertension	9.98e-07	1.73e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PIK3R1—hypertension	9.88e-07	1.71e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—NOS3—hypertension	9.88e-07	1.71e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IGF1—hypertension	9.81e-07	1.7e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—AKT2—hypertension	9.8e-07	1.7e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—EGFR—hypertension	9.76e-07	1.69e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PTEN—hypertension	9.71e-07	1.68e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MMP9—hypertension	9.68e-07	1.67e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCL8—hypertension	9.66e-07	1.67e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CDKN1A—hypertension	9.65e-07	1.67e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PTEN—hypertension	9.62e-07	1.66e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—RELA—hypertension	9.58e-07	1.66e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—POMC—hypertension	9.48e-07	1.64e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—RELA—hypertension	9.43e-07	1.63e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—INS—hypertension	9.42e-07	1.63e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MAPK8—hypertension	9.41e-07	1.63e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MTOR—hypertension	9.39e-07	1.62e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—AKT1—hypertension	9.39e-07	1.62e-05	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—AKT1—hypertension	9.33e-07	1.61e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SERPINE1—hypertension	9.32e-07	1.61e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCL2—hypertension	9.27e-07	1.6e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—EP300—hypertension	9.26e-07	1.6e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MTOR—hypertension	9.24e-07	1.6e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL6—hypertension	9.19e-07	1.59e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—EP300—hypertension	9.18e-07	1.59e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IGF1—hypertension	9.12e-07	1.58e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—AKT2—hypertension	9.11e-07	1.58e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—EGFR—hypertension	9.07e-07	1.57e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PTGS2—hypertension	9.04e-07	1.56e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCL8—hypertension	9.03e-07	1.56e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—FGF2—hypertension	9.02e-07	1.56e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RHOA—hypertension	8.99e-07	1.55e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—SRC—hypertension	8.92e-07	1.54e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NOS3—hypertension	8.89e-07	1.54e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PIK3R1—hypertension	8.89e-07	1.54e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCL8—hypertension	8.88e-07	1.54e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MMP9—hypertension	8.74e-07	1.51e-05	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—AKT1—hypertension	8.72e-07	1.51e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CDKN1A—hypertension	8.71e-07	1.51e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—VEGFA—hypertension	8.69e-07	1.5e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PTEN—hypertension	8.69e-07	1.5e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SERPINE1—hypertension	8.66e-07	1.5e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL6—hypertension	8.58e-07	1.48e-05	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—AKT1—hypertension	8.58e-07	1.48e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MAPK8—hypertension	8.5e-07	1.47e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—AKT1—hypertension	8.48e-07	1.47e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL6—hypertension	8.45e-07	1.46e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—FGF2—hypertension	8.38e-07	1.45e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RELA—hypertension	8.37e-07	1.45e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RHOA—hypertension	8.35e-07	1.44e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—EP300—hypertension	8.29e-07	1.43e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NOS3—hypertension	8.26e-07	1.43e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PIK3R1—hypertension	8.26e-07	1.43e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MTOR—hypertension	8.21e-07	1.42e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MMP9—hypertension	8.16e-07	1.41e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CDKN1A—hypertension	8.13e-07	1.41e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PTEN—hypertension	8.12e-07	1.4e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SRC—hypertension	8.06e-07	1.39e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MMP9—hypertension	8.03e-07	1.39e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CDKN1A—hypertension	8.01e-07	1.38e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MYC—hypertension	8e-07	1.38e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PTEN—hypertension	7.99e-07	1.38e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TGFB1—hypertension	7.98e-07	1.38e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MAPK8—hypertension	7.94e-07	1.37e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—AKT1—hypertension	7.92e-07	1.37e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCL8—hypertension	7.89e-07	1.36e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PTEN—hypertension	7.88e-07	1.36e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—VEGFA—hypertension	7.85e-07	1.36e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—EGFR—hypertension	7.82e-07	1.35e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MAPK8—hypertension	7.81e-07	1.35e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—AKT1—hypertension	7.79e-07	1.35e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RELA—hypertension	7.78e-07	1.35e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—EP300—hypertension	7.74e-07	1.34e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MTOR—hypertension	7.63e-07	1.32e-05	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—AKT1—hypertension	7.62e-07	1.32e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—EP300—hypertension	7.62e-07	1.32e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SRC—hypertension	7.53e-07	1.3e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—EP300—hypertension	7.52e-07	1.3e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL6—hypertension	7.5e-07	1.3e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SRC—hypertension	7.41e-07	1.28e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCL8—hypertension	7.33e-07	1.27e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—VEGFA—hypertension	7.33e-07	1.27e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MYC—hypertension	7.22e-07	1.25e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—VEGFA—hypertension	7.21e-07	1.25e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TGFB1—hypertension	7.2e-07	1.25e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MMP9—hypertension	7.14e-07	1.23e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CDKN1A—hypertension	7.11e-07	1.23e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PTEN—hypertension	7.09e-07	1.23e-05	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—AKT1—hypertension	7.08e-07	1.23e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—EGFR—hypertension	7.06e-07	1.22e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL6—hypertension	6.97e-07	1.21e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MAPK8—hypertension	6.94e-07	1.2e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—AKT1—hypertension	6.92e-07	1.2e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—EP300—hypertension	6.77e-07	1.17e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MYC—hypertension	6.74e-07	1.17e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TGFB1—hypertension	6.73e-07	1.16e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MYC—hypertension	6.64e-07	1.15e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MMP9—hypertension	6.63e-07	1.15e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TGFB1—hypertension	6.62e-07	1.15e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CDKN1A—hypertension	6.61e-07	1.14e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—EGFR—hypertension	6.6e-07	1.14e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PTEN—hypertension	6.59e-07	1.14e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SRC—hypertension	6.58e-07	1.14e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TP53—hypertension	6.57e-07	1.14e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—EGFR—hypertension	6.49e-07	1.12e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MAPK8—hypertension	6.45e-07	1.12e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—AKT1—hypertension	6.43e-07	1.11e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—VEGFA—hypertension	6.41e-07	1.11e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—EP300—hypertension	6.29e-07	1.09e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SRC—hypertension	6.11e-07	1.06e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL6—hypertension	6.01e-07	1.04e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—VEGFA—hypertension	5.95e-07	1.03e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TP53—hypertension	5.93e-07	1.03e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MYC—hypertension	5.9e-07	1.02e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TGFB1—hypertension	5.88e-07	1.02e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—EGFR—hypertension	5.77e-07	9.98e-06	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—AKT1—hypertension	5.59e-07	9.68e-06	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—AKT1—hypertension	5.55e-07	9.59e-06	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TP53—hypertension	5.54e-07	9.58e-06	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MYC—hypertension	5.48e-07	9.48e-06	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TGFB1—hypertension	5.46e-07	9.45e-06	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TP53—hypertension	5.45e-07	9.43e-06	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6—hypertension	5.43e-07	9.39e-06	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—EGFR—hypertension	5.36e-07	9.27e-06	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6—hypertension	5.07e-07	8.77e-06	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—AKT1—hypertension	5.01e-07	8.66e-06	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6—hypertension	4.99e-07	8.63e-06	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TP53—hypertension	4.84e-07	8.38e-06	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—AKT1—hypertension	4.68e-07	8.09e-06	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—AKT1—hypertension	4.6e-07	7.96e-06	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—AKT1—hypertension	4.54e-07	7.86e-06	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TP53—hypertension	4.5e-07	7.78e-06	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6—hypertension	4.43e-07	7.67e-06	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6—hypertension	4.12e-07	7.12e-06	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—AKT1—hypertension	4.09e-07	7.07e-06	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—AKT1—hypertension	3.8e-07	6.57e-06	CbGpPWpGaD
